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Fine particle components and health—a systematic review and
meta-analysis of epidemiological time series studies of daily
mortality and hospital admissions
Richard W. Atkinson1, Inga C. Mills2, Heather A. Walton3,4 and H. Ross Anderson1,3
Short-term exposure to ﬁne particle mass (PM) has been associated with adverse health effects, but little is known about the
relative toxicity of particle components. We conducted a systematic review to quantify the associations between particle
components and daily mortality and hospital admissions. Medline, Embase and Web of Knowledge were searched for time series
studies of sulphate (SO4
2− ), nitrate (NO3
−), elemental and organic carbon (EC and OC), particle number concentrations (PNC) and
metals indexed to October 2013. A multi-stage sifting process identiﬁed eligible studies and effect estimates for meta-analysis.
SO4
2− , NO3
−, EC and OC were positively associated with increased all-cause, cardiovascular and respiratory mortality, with the
strongest associations observed for carbon: 1.30% (95% CI: 0.17%, 2.43%) increase in all-cause mortality per 1 μg/m3. For PNC, the
majority of associations were positive with conﬁdence intervals that overlapped 0%. For metals, there were insufﬁcient estimates
for meta-analysis. There are important gaps in our knowledge of the health effects associated with short-term exposure to particle
components, and the literature also lacks sufﬁcient geographical coverage and analyses of cause-speciﬁc outcomes. The available
evidence suggests, however, that both EC and secondary inorganic aerosols are associated with adverse health effects.
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INTRODUCTION
Exposure to outdoor particulate matter with a median aero-
dynamic diameter o2.5 microns (PM2.5) has been associated with
a range of adverse health outcomes.1–3 Epidemiological evidence
comes from cohort studies linking long-term exposure to PM2.5 to
adverse health effects and from time series studies that have
reported associations between daily concentrations of PM2.5 and
increases, within a period of days, in daily numbers of deaths and
emergency hospital admissions.
PM2.5 mass is regulated in the United States, Europe and
elsewhere but no consideration is given to particle size, source or
chemical composition. Policy makers and regulatory authorities
have sought to establish which, if any, component of the particle
mixture is most dangerous to human health.2 To date, literature
reviews have focused on speciﬁc components, such as black
carbon;4,5 or speciﬁc sources such as trafﬁc;6 have been limited by
the relatively sparse literature available for review;7–9 or have been
restricted to speciﬁc geographical regions.10,11 Other reviews
have not provided a systematic, quantitative assessment of the
evidence but relied instead upon a qualitative review of a range
of study designs and health outcomes.2,12–14 We conducted a
systematic review of the epidemiological time series literature
for adverse effects of particle components on mortality and
hospital admissions using original research indexed in online
databases to October 2013 and without limitation by geographical
region, particle component or source or language. We included
studies of secondary inorganic aerosols, elemental and organic
carbon and size-fractionated particle number concentrations.
Our focus was the selection of effects estimates for meta-
analysis to provide concentration-response functions for com-
parative purposes and for health impact assessment. We also
provide a qualitative overview of the growing time series literature
reporting results for the elemental content of particles.
MATERIALS AND METHODS
The Air Pollution Epidemiology Database (APED)15 was used to identify
ecological time series studies of the health effects associated with short-
term exposure to a range of particle metrics: nitrate (NO3
−); sulphate (SO4
2− );
elemental (EC) and organic (OC) carbon; and size-fractionated particle
number concentrations (PNC), including nucleation mode (particles with a
diameter generally o0.05 μm), Aitken mode (generally 0.05–0.1 μm) and
accumulation mode (generally 0.1–0.5 μm)6,16,17 and metals. APED and our
systematic review protocol have been described previously.3,15,18 In brief,
APED contains details of time series studies (including case crossover
designs) published in peer reviewed journals and indexed in PubMed,
EMBASE or Web of Science (which includes the Science Citation Index).
Studies are identiﬁed through periodic searches using the following search
criteria: “(particle* or particulate* or aerosol or sulphate or nitrate or carbon
or metal) and (timeseries or time-series or time series) and (mortality or
death* or dying or hospital admission* or admission* or emergency)”. For
this review, studies of particle components indexed up to October 2013
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were included. We also cross-checked studies identiﬁed in APED against
publications selected for other reviews2,9 and publications from the Health
Effects Institute.6,13,19 APED includes only studies that meet speciﬁc criteria,
including: (1) at least 1 year of daily data relating to a general population;
(2) a reasonable attempt to control for important confounding factors,
such as long-term temporal trends, season and meteorological conditions;
and (3) sufﬁcient information for the calculation of a regression estimate
and standard error (SE) for inclusion in the quantitative analysis.
Study details were entered into a Microsoft Access database and
included publication details, and all data required to characterize the
health outcomes, pollutants and effect estimates. From these data, we
calculated standardized effect estimates expressed as the percentage
change (and 95% conﬁdence interval) in the mean number of daily events
associated with a 1-μg/m3 increase in particle concentrations.
A multi-stage process to select estimates for meta-analysis avoided
duplication by selecting the most recently published evidence. Meta-
analysis was performed only when ≥ 4 estimates for an outcome/disease/
age group were available. Summary estimates were derived using a
random-effects model, which calculates a weighted summary estimate
using weights determined from the precision of individual study effect
estimates.20 The random-effects model assumes that the associations
observed in individual studies can vary because of real differences between
the associations in each study as well as simple sampling variability
(chance) between studies and adjusts the pooled estimates and their 95%
conﬁdence intervals accordingly. Where sufﬁcient estimates were avail-
able, we carried out stratiﬁed analyses by WHO region (details of countries
included in each region are available at http://www.who.int/choice/
demography/regions/en/) to assess geographical variation. Heterogeneity
between study estimates was assessed using the I2 statistic,21 which
describes the proportion of the variation in effect estimates attributable to
heterogeneity rather than chance.
All analyses were conducted in STATA (STATA/SE 10. StataCorp,
Texas, USA).
RESULTS
Literature Search
Our review identiﬁed 63 studies indexed in medical databases to
October 2013. Two studies were excluded from our review: a
reanalysis of the existing data sets22 and one that was unavailable
online23. Of the 61 studies, 40 investigated daily mortality and 27
hospital admissions. Secondary inorganic aerosols were investigated
in 35 studies (SO4
2− ), 11 of which also considered NO3
−; elemental
and organic carbon was investigated in 19 studies; particle number
concentrations in 12 studies; and particle elemental composition
in 19 studies. Table 1 gives the numbers of studies by outcome,
disease category and particle metric investigated stratiﬁed by
WHO Region. The majority of studies were from North America
and Europe although we note the very recent growth in studies
from China (published in 2011–12). A number of cities were the
subject of investigation on multiple occasions, both in single- and
multi-city studies. A bibliography for the 63 studies included in our
review is given in the Supplementary Data.
Secondary Inorganic Aerosols and Elemental and Organic Carbon
Mortality. Summary estimates (95% conﬁdence intervals) per
1 μg/m3 increment in SO4
2− , NO3
−, EC and OC for all-age, all-cause
and cause-speciﬁc mortality are presented in Table 2. Individual
study results are presented in a series of forest plots in the
(Supplementary Figures S1–S12). The number of all-cause mortality
estimates selected for meta-analysis was largest for SO4
2− (12)
compared with 6, 6 and 4 for NO3
−, EC and OC, respectively. All four
metrics were positively associated with increased all-cause
mortality; the largest association per unit mass for elemental
carbon, 1.30% (95% CI: 0.17%, 2.43%) and the lowest for SO4
2− ,
0.15% (0.06%, 0.25%). All pollutants were positively associated
with cardiovascular mortality, between 1.66% (0.52%, 2.81%) for
EC and 0.11% (−0.12%, 0.35%) for NO3
−. Associations with respira-
tory mortality were broadly comparable to those for cardiovas-
cular disease although in all cases conﬁdence intervals straddled
0%. For all but one outcome, there was a strong evidence of
between-study heterogeneity.
For SO4
2− , sufﬁcient estimates were available for a subgroup
analysis by WHO region (Figure 1). There was evidence of
heterogeneity between WHO regions for all-cause mortality
(χ2 = 15.0; P= 0.001), cardiovascular (χ2 = 5.2; P= 0.08) and respira-
tory mortality (χ2 = 4.7; P = 0.10). For each disease group, asso-
ciations in North America were larger than in European and
Western Paciﬁc regions. Mortality associations for secondary
inorganic aerosols and carbon were reported for a range of other
disease/age group combinations but with too few estimates for
meta-analysis.
Hospital admissions. Both cardiovascular (including cardiac) and
respiratory hospital admissions in all-ages/65+ years were
associated with increases in SO4
2− : 0.12% (−0.04%, 0.29%) (5
estimates, I2= 61%) and 0.14% (−0.07%, 0.35%) (6 estimates,
I2= 57%) per 1 μg/m3, respectively. Individual study results are
presented in Supplementary Figures S13 and S14. For NO3
−, EC
and OC, there were insufﬁcient numbers of estimates to carry out
a meaningful meta-analysis. We note, however, the ﬁndings from
a large, multi-city study of 119 US counties reporting positive
associations for EC and mixed evidence for NO3
− and OC and both
cardiovascular and respiratory admissions.9
Particle Number Concentrations
Studies of PNC concentrations assessed a range of size-
fractionated number concentrations in relation to daily mortality.
After application of our estimate selection protocol, there were
too few estimates within each disease/mode grouping to carry out
separate meta-analyses. Figure 2 summarizes the results for
mortality for nucleation, Aitkin/accumulation mode particles and
for total number concentrations where reported in the selected
studies. The ﬁgure shows results scaled by interquartile range for
individual metrics to facilitate within-, rather than between-, study
comparison. Although the majority of associations were positive,
most had conﬁdence intervals that overlapped 0 (%), and little
pattern in the associations could be discerned between the
different modes. For PNC and hospital admissions, there were
insufﬁcient numbers of estimates to carry out a meaningful meta-
analysis (data not shown).
Table 1. Numbers of time series studies stratiﬁed by outcome, disease, particle metric and continent.
Continent (WHO region codes) Outcome Disease Particle metric
Mortality Admissions All cause Cardiovascular Respiratory SO4
2- NO3
- EC/OC PNC Metals
North America (AMR A & B) 21 20 16 21 20 29 6 13 — 12
South America (AMR C) 2 1 1 2 3 — — 2 — 2
Europe (EUR A, B & C) 10 7 7 11 8 3 2 — 10 1
Western Paciﬁc (WPR B) 7 — 5 6 5 3 3 4 2 4
Total 40 28 29 40 36 35 11 19 12 19
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Table 3 summarizes the scope and main ﬁndings of the 19 studies
reporting results for the elemental content of particles. Studies
from North America dominate the available literature (11 from the
USA and 2 from Canada). Daily mortality and hospital admissions
were investigated in 14 and 5 studies, respectively, and a range of
the metals studied (between 3 and 57 elements). Fourteen studies
reported regression coefﬁcients for individual elemental concen-
trations, and ﬁve studies reported coefﬁcients for PM2.5 mass in
proportion to elemental composition. For mortality, zinc was
positively associated with daily mortality in 8/11 studies, nickel in
5/9 studies and vanadium in 3/5 studies.
DISCUSSION
Our review identiﬁed a growing literature regarding the health
effects associated with short-term exposure to particle compo-
nents, including secondary aerosols, carbon, particle number
concentrations and metals. In the 3 years since the last review of
the literature on secondary aerosols and carbon and mortality and
hospital admissions,9 the number of published studies has
increased by 50% (14–21). Furthermore, the broad search strategy
used for our review identiﬁed an additional 26 population-based
time series studies of mortality and hospital admissions, with
additional studies including PNC and metals. Although the
majority of the studies in our review were still from North
America, we note the very recent growth in the number of studies
conducted in Asia (six studies in 2012) covering a range of health
outcomes and particle metrics. The larger number and scope of
studies included in our review has therefore enabled: (1) the
quantiﬁcation of associations between secondary aerosols and
carbon and cause-speciﬁc mortality; (2) quantiﬁcation for sulphate
and respiratory and cardiovascular admissions; and (3) a
comprehensive, descriptive assessment of the evidence for PNC
and metals.
In our review, meta-analytical summary estimates were positive
but lacked precision for most cause-speciﬁc mortality groups.
The largest association observed was for elemental carbon, 1.3%
increase in all-cause mortality per 1 μg/m3 increase in EC based
upon only six studies from the United States, Chile, China and
South Korea. Previous reviews of EC have incorporated results for
Black Smoke (a light reﬂectance measurement method calibrated
to mass concentration) in their analyses due to the sparseness of
direct estimates for EC and have tended to report smaller effect
estimates.5,9 We also note the strong heterogeneity between
these six estimates and the lack of adjustment for co-pollutants,
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Figure 1. Region-speciﬁc summary estimates for the associations between sulphate and all-cause and cause-speciﬁc mortality.
Table 2. Random effects summary estimates for particle metrics and all-cause and cause-speciﬁc mortality.
Pollutant Disease All SC/MCa Selected SC/MCb RE (95% CI)c I2 (%)d
SO4
2- All-cause 14/4 9/3 0.15 (0.06, 0.25) 71
Cardiovascular 9/1 8/1 0.21 (−0.01, 0.44) 42
Respiratory 8/1 7/1 0.23 (−0.07, 0.52) 38
NO3
- All-cause 6/1 5/1 0.17 (0.12, 0.23) 0
Cardiovascular 6/1 5/1 0.11 (−0.12, 0.35) 70
Respiratory 4/1 3/1 0.15 (−0.29, 0.59) 68
EC All-cause 6/1 5/1 1.30 (0.17, 2.43) 92
Cardiovascular 5/1 4/1 1.66 (0.52, 2.81) 97
Respiratory 4/1 3/1 1.09 (−1.59, 3.85) 99
OC All-cause 4/1 3/1 0.37 (−0.19, 0.94) 99
Cardiovascular 5/1 4/1 0.56 (0.01, 1.10) 97
Respiratory 4/1 3/1 0.57 (−1.11, 2.28) 98
aNumber of estimates available from all single/multi-city studies. bNumber of estimates from single/multi-city studies selected for meta-analysis (see Methods
for details of estimate selection protocol). cRandom effects summary estimate expressed as percentage of change in the number of deaths per 1 μg/m3 (95%
conﬁdence interval). dI2 percentage of between-city variability attributed to heterogeneity.
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both of which require careful investigation before assigning
prominence to these ﬁndings.
Our ﬁndings for SO4
2− and NO3
− and mortality were consistent
with the ﬁndings of Levy et al.9 but are based upon a broader
geographical literature incorporating evidence from Asia and
without duplication of study locations. To our knowledge, our
summary estimates for SO4
2− and NO3
− and hospital admissions for
cardiovascular and respiratory disease are new. However, they are
dominated by the 119 US counties study,9 with little evidence
available from other parts of the world. The literature is also sparse
for studies of speciﬁc disease sub-groups and tends to be limited
to North America, Europe and Western Paciﬁc region.
Ultraﬁne particles (UFP) are characterized by size (o100 nm),
high numbers and relatively large surface area. Our review found
little consistent evidence of an association between UFP and daily
mortality—a conclusion also reached in recent reviews.1,2,19 UFPs
are also characterized in terms of the particle size; nucleation
mode particles (o50 nm in diameter) result from gas-to-particle
conversion of different chemical compounds and Aitken mode
particles (50–100 nm) by direct emission from combustion
processes, for example, soot particles from cars.6 In our review,
neither modes were differentiated in terms of their effects on
mortality although the evidence base was too limited to draw ﬁrm
conclusions. Of the 15 studies of UFP identiﬁed for review, 10 were
conducted in just four locations: Erfurt (4), Helsinki (2), Copenha-
gen (2) and Beijing (2). A broader geographical study base would
therefore be advantageous in building a more complete picture of
the evidence for the adverse health effects of UFP.
Our qualitative review of the literature reporting results for the
elemental content of particles suggests that in the majority of
studies Zn, Ni and vanadium were associated with increased
mortality. Zn may be indicative of a road dust and possibly a tyre
wear source, Fe and Zn are linked to steel production and Ni
linked to oil combustion24 or, in a speciﬁc case, to a Nickel smelter.25
Our qualitative review highlighted some of the difﬁculties in
assessing the relative effects of particle elemental composition:
(1) studies varied in the range of metals investigated making
synthesis difﬁcult; (2) in a number of studies measurements
were frequently below detection limits13 or not measured daily,26
reducing statistical power; (3) measurements were poorly corre-
lated across monitor locations or measured at one location only
with the potential for exposure measurement error;27–29 and
(4) statistical methods varied with some studies considering mass
concentrations of individual elements and others reporting coefﬁ-
cients for PM2.5 apportioned by elemental composition. The need
to properly account for potential confounding by PM2.5 in the
analyses of particle constituents has been suggested by Mostofsky
et al30 adding to the difﬁculty in synthesizing the evidence. A
signiﬁcant strength of these studies, however, is their ability to
characterize fully the particle mixture. Some studies that have
characterized particles fully have utilized source apportionment
techniques.31–32 However, they have not been included in our
review as they do not report numerical coefﬁcients suitable for
inclusion in a quantitative review and meta-analysis for health impact
assessment, but we recognize the policy relevance of identifying PM
source components most associated with adverse health outcomes.
Finally, as for particle numbers, a broader geographical study base
would be helpful in identifying the toxic components of particles
and deriving concentration-response functions.
Our study had a number of strengths, including a very recent
literature search (to October 2013); an a priori protocol for the
identiﬁcation of relevant studies and selection of effect estimates
for meta-analysis to minimize selection bias; and no limitations on
language (although all of the studies were written in English). Our
study protocol ensured that multiple results from a single location
did not have a disproportionate inﬂuence upon summary
estimates. However, this approach reduced the number of meta-
analyses possible when the evidence was limited to a small
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Figure 2. Individual study results for particle number concentrations and mortality.
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Table 3. Summary of main ﬁndings from studies of elemental content of particles.
First Author Year City/country Diseases Study period Pollutants Statistical approach Findings
Hoek 1997 Rotterdam,
Netherlands
All-cause mortality 1983–1991 Fe Poisson regression, single
pollutant
No statistically signiﬁcant associations with
mortality
Burnett 2000 8 cities in Canada All-cause mortality 1986–1996 47 elements Poisson regression, single
pollutant
Fe, Ni, and Zn were most strongly associated with
increased mortality. Fine-fraction of Ca, Cu, Sc, Co,
Zr, P, La and Mg were also found to have some
association with mortality
Mar 2000 Phoenix, USA All-cause and
cardiovascular mortality
1995–1997 S, Zn, Pb Poisson regression, single
pollutant
S and Pb negatively associated with total
mortality. No other statistically signiﬁcant
associations. Metals represent between 0.3 and
0.5% of total PM2.5 mass
Cancado 2006 Piracicaba, Brazil Respiratory hospital
admissions
1997–1998 Al, Si, S, K and Mn Poisson regression, single
pollutant
Al, Si, S, K and Mn signiﬁcantly associated with
child respiratory admissions. K associated with
elderly respiratory hospital admissions. Biomass
burning predominant source of particles
Lippmann 2006 60 MSAs in USA Mortality 2000–2003 Al, As, Cr, Cu, Fe, Mn, Ni,
Pb, Se, Si, V, Zn
Meta-regression of PM10 risk on
components
PM10 risk coefﬁcients were high in MSAs where Ni
and V were signiﬁcantly high (95th percentile)
compared with the MSAs where Ni was low (5th
percentile)
Brook 2007 10 cities in Canada All-cause mortality 1980–2000 Fe, Zn, Ni, Mn, As, Al, Cu,
Pb, Si, Se
Poisson regression, single
pollutant
Zn and Pb signiﬁcantly associated with increased
mortality; Ni borderline signiﬁcance. All others
(except Al) positive but not statistically signiﬁcant
Ostro 2007 6 California
counties, USA
All-cause, cardiovascular
and respiratory mortality
2000–2003 Al, Br, Ca, Cl, Cu, Fe, K,
Mn, Ni, Pb, S, Si, Ti, V, Zn
Poisson regression, single
pollutant
Strongest associations were observed for Cu, K, Ti
and Zn. All except Al, Br, Cu and Ni positively and
signiﬁcantly associated with all-cause mortality in
cooler months
Franklin 2008 25 US
communities
All-cause, cardiovascular
and respiratory mortality
2000–2005 Al, As, Br, Cr, Fe, K, Mn, Ni,
Pb, Si, V, Zn
Meta-regression of PM2.5 risk on
components
PM2.5 association higher when PM2.5 mass
contained a higher proportion of Al, Arsenic, Si
and Ni
Ostro 2009 6 California
counties, USA
Respiratory hospital
admissions
2000–2003 Cu, Fe, K, Si, Zn Poisson regression, single
pollutant
Cu, Fe and Si signiﬁcantly associated with
increased respiratory admissions and Cu, Fe
and Si with asthma admissions in subjects
aged o19 years
Ito 2010 New York, USA Cardiovascular mortality
and hospital admissions
2000–2006 Ni, V, Zn, Si, Se, Br Poisson regression, single
pollutant
Se showed a strong association with CVD
mortality as did Br (warm season only). Ni, V and
Zn associated with CVD mortality (stronger in
cold season). Ni, Zn, Si, Se and Br associated with
CVD hospitalizations (strongest in the cold
season
Suh 2011 Atlanta, USA Cardiovascular and
respiratory hospital
admissions
1998–2006 Transition metal oxides
of Cu, Mn, Zn, Ti, Fe
Two stage: Logistic regression
and meta-regression to
categories
Consistent and signiﬁcant associations between
transition metals and increased hospital
admissions for CVD, CHF and IHD in both
ﬁrst-stage and second-stage analyses
Zhou 2011 Detroit and
Seattle, USA
All-cause, cardiovascular
and respiratory mortality
2002–2004 Al, Fe, K, Na, Ni, S, Si, V,
Zn
Poisson regression, single
pollutant
Detroit: Warm season, S positively associated with
AC and CV mortality. Seattle: cold season, Al, K, Si
and Zn positively associated with AC and CV
mortality
Valdes 2012 Santiago, Chile All-cause, cardiovascular
and respiratory mortality
1998–2007 Al, Na, Si, S, Cl, Ca, Cr,
Mn, Ni, K, Fe, Cu, Zn, Se,
Br, Pb
Poisson regression using mean
monthly ratio of each individual
element to PM2.5 mass
Zn associated with higher cardiovascular
mortality. Particles with high content of Cr, Cu
and S showed stronger associations with
respiratory and COPD mortality. Zn and Na
content of PM2.5 ampliﬁed the association with
cerebrovascular disease
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number of locations that were repeatedly studied. Other limita-
tions of our review included potential bias arising from reliance
upon authors’ selection of results to submit for publication and
limited ability to investigate reasons for the heterogeneity
observed between studies. New studies are required to assess
fully the impact of these factors upon the size and precision of the
concentration-response functions derived in our meta-analysis.
Our review focused upon the evidence from single pollutant
models as our primary aim was quantiﬁcation of effect estimates
using meta-analysis. However, a single pollutant approach
provides only limited insight into the differential toxicity of
particle constituents, a point noted by Levy et al.9 The literature for
multi-constituent models remains limited with heterogeneity in
the analytical methods used and the reporting of results.
The current literature is dominated by studies of mortality from
broad disease categories. Few studies have reported effect
estimates for speciﬁc causes of death, for example, from ischaemic
heart disease, stroke or COPD or for age- and disease-speciﬁc
hospital admissions. Furthermore, only a handful of studies have
considered a range of health end points, diseases and particle
components in the same population and hence facilitating
meaningful within-study comparison. The literature is also
dominated by studies from North America although we note the
recent increase in studies from Asia. Further studies from other
developed, and developing, countries, are needed to conﬁrm the
observed associations. Also, additional studies including speciﬁc,
rather than broad, categories of diseases would provide additional
understanding of the populations at risk and may also add to our
understanding of mechanism of effect.
Fine particle mass (PM2.5) has been studied and reviewed
extensively, and little doubt remains regarding the adverse health
effects of both long- and short-term exposure.2,8,11,24,33,34 How-
ever, the uncertainty regarding the components of PM responsible
for the adverse health effects remains despite efforts to evaluate
the relative toxicity of the various chemical and physical proper-
ties of PM.2,9,13,14 Our review of the time series literature provides
support for these conclusions although we note, albeit with some
caution as our analyses were based upon single-pollutant models
only, the larger relative risks for mortality per unit mass of EC
compared with other metrics. It should be noted that the
interquartile range for EC is much smaller than for sulphate and
nitrate aerosol and that both potency and total impact are
relevant for policy decisions. A recent review of the toxicological
literature35 concluded that the limited new evidence did not
change the view from an earlier review36 that secondary inorganic
aerosols “have little biological potency in normal human beings”.
They do, however, offer a word of caution noting that “it cannot
be excluded that these secondary inorganic components produce
an interactive biological effect with constituents of the overall
pollutant mix by, for example, inﬂuencing the bioavailability of
other components, such as metals”. The authors of the 2013
review also note a word of caution regarding elemental carbon
suggesting “(EC) may not be a major directly toxic component of
ﬁne PM” and suggesting, as for secondary inorganic aerosols, that
it may act as a “a universal carrier of a wide variety of combustion
derived chemical constituents of varying toxicity to sensitive
targets in the human body”.
The NPACT investigators recommended that further studies
should improve individual and population exposure estimates
before “it can be concluded that regulations targeting speciﬁc
sources or components of PM2.5 will protect public health more
effectively than continuing to follow the current practice of
targeting PM2.5 mass as a whole”.
13,14 Systematic review and
quantitative meta-analysis will continue to have an important role
in collating and combining the growing body of evidence. Further
characterization of air pollution environments and sources will
also enable the between-study heterogeneity and any potential
confounding to be investigated further improving ourT
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understanding of the role of speciﬁc particle components. In the
mean time, we recommend that the potential health beneﬁts of
air pollution mitigation policies are evaluated for a range of
particle metrics, particularly elemental carbon, in addition to a
single mass metric.
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